German Firm Cited for Procedural, Quality Control Shortcomings

Drug Industry Daily
A A
The FDA hit BODE Chemie with a Form 483 for failing to follow proper quality control procedures, in addition to other deficiencies at its facility in Hamburg, Germany.

To View This Article:

Login

Subscribe To Drug Industry Daily